Effect of second-stage 0.25% epidural bupivacaine on the outcome of labor

Dov Luxmana, Igal Wolman, David Niv, Jacob R. Cohen, Michel Lottan, David Pauzner, Asnat Groutz, Menachem P. David

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To evaluate the effect of second-stage epidural bupivacaine on the outcome of labor. Methods: Two groups of 35 patients each were randomly allocated to receive continuous epidural bupivacaine throughout labor (group 1) or until an 8-cm dilatation of the cervix (group 2). Results: There was no significant difference between the 2 groups in the rates of instrument deliveries and in their Apgar scores. Conclusions: The administration of continuous epidural bupivacaine (0.25%) throughout labor and delivery does not seem to affect the outcome of labor.

Original languageEnglish
Pages (from-to)167-170
Number of pages4
JournalGynecologic and Obstetric Investigation
Volume42
Issue number3
DOIs
StatePublished - 1 Jan 1996

Keywords

  • Epidural bupivacaine
  • Labor
  • Second stage

Fingerprint

Dive into the research topics of 'Effect of second-stage 0.25% epidural bupivacaine on the outcome of labor'. Together they form a unique fingerprint.

Cite this